Affinity Chromatography Solutions for Commercial Adeno-Associated Virus Manufacturing
Gene therapy can include efforts to fix dysfunctional genes or to deliver DNA to a target cell. One way to deliver DNA is to use viral vectors – viruses that don’t cause disease in humans – that have been engineered to efficiently deposit their genetic information in targeted human cells.
Recombinant adeno-associated viruses (AAVs) have become the viral vectors of choice for many gene therapy applications due to their history of low immunogenicity and good clinical outcomes
Download this whitepaper to learn more about:
Improving AAV yield and purity using affinity resins
How affinity purification can contribute to viral clearance